The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections

References

• Fisher K, Phillips C. The ecology, epidemiology and virulence of Enterococcus. Microbiology. 2009;155(Pt 6):1749–1757.
   PubMed Web of Science ®Google Scholar
• Lebreton F, van Schaik W, Manson McGuire A, et al. Emergence of epidemic multidrug-resistant Enterococcus faecium from animal and commensal strains. mBio. 2013;4(4):e00534-13.
   PubMed Web of Science ®Google Scholar
• Lee T, Pang S, Abraham S, et al. Antimicrobial-resistant CC17 Enterococcus faecium: The past, the present and the future. J Glob Antimicrob Resist. 2019;16:36–47.
   PubMed Web of Science ®Google Scholar
• Wittea RW W, Klarea I. Enterococcus. Chemotherapy. 1999;45:135–145.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Du M, Chang Y, et al. Incidence, clinical characteristics, and outcomes of nosocomial Enterococcus spp. bloodstream infections in a tertiary-care hospital in Beijing, China: a four-year retrospective study. Antimicrobial Resistance & Infection Control. 2017;6(1):73.
   PubMed Web of Science ®Google Scholar
• Arias CA, Murray BE. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol. 2012;10(4):266–278.
   PubMed Web of Science ®Google Scholar
• Coombs GW, Daley DA, Lee YT, et al. Australian group on antimicrobial resistance (AGAR) Australian Enterococcal Sepsis outcome Programme (AESOP) Annual report 2017. Commun Dis Intell (2018). 2019;43.
   Google Scholar
• Willems RJL, Top J, van Santen M, et al. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerging Infect Dis. 2005;11(6):821–828.
   PubMed Web of Science ®Google Scholar
• ECDC. Surveillance of antimicrobial resistance in Europe 2018. Stockholm: European Centre for Disease Prevention and Control; 2019.
   Google Scholar
• Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med. 2000;342(10):710–721.
   PubMed Web of Science ®Google Scholar
• Weigel LM, Clewell DB, Gill SR, et al. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science. 2003;302(5650):1569–1571.
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327.
   PubMed Web of Science ®Google Scholar
• CDC. Antibiotic resistance threats in the United States, 2019. Atlanta (GA): Antibiotic Resistance Coordination and Strategy Unit within the Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention; 2019.
   Google Scholar
• Peta M, Carretto E, Barbarini D, et al. Outbreak of vancomycin-resistant Enterococcus spp. in an Italian general intensive care unit. Clin Microbiol Infect. 2006;12(2):163–169.
   PubMed Web of Science ®Google Scholar
• Markwart R, Willrich N, Haller S, et al. The rise in vancomycin-resistant Enterococcus faecium in Germany: data from the German antimicrobial resistance surveillance (ARS). Antimicrob Resist Infect Control. 2019;8:147.
   PubMed Web of Science ®Google Scholar
• Sun H, Wang H, Xu Y, et al. Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates recovered from hospitalized patients among several medical institutions in China. Diagn Microbiol Infect Dis. 2012;74(4):399–403.
   PubMed Web of Science ®Google Scholar
• Conceição N, Oliveira C, Silva P, et al. Trends in antimicrobial resistance among clinical isolates of enterococci in a Brazilian tertiary hospital: a 4-year study. Rev Soc Bras Med Trop. 2011;44:177–181.
   PubMed Web of Science ®Google Scholar
• Mendes RE, Castanheira M, Farrell DJ, et al. Longitudinal (2001–14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010–13) analysis of oritavancin in vitro potency. J Antimicrob Chemother. 2016;71(12):3453–3458.
   PubMed Web of Science ®Google Scholar
• Tripathi A, Shukla S, Singh A, et al. Prevalence, outcome and risk factor associated with vancomycin-resistant Enterococcus faecalis and Enterococcus faecium at a Tertiary care hospital in Northern India. Indian J Med Microbiol. 2016;34(1):38–45.
   PubMed Web of Science ®Google Scholar
• Nelson I, Agudelo Higuita MMH. Enterococcal disease, epidemiology, and implications for treatment. In: Enterococci: from commensals to leading causes of drug resistant infection [Internet]. Boston: Massachusetts Eye and Ear Infirmary; 2014. Available from: https://www.ncbi.nlm.nih.gov/books/NBK190429/
   Google Scholar
• Saeidi S, Mirnejad R, Masoumi Zavaryani S, et al. Molecular epidemiology and antibiotic resistance patterns of Enterococcus faecalis isolates from hospitals in Tehran. Infez Med. 2017;25(2):116–122.
   PubMedGoogle Scholar
• Dai D, Wang H, Xu X, et al. The emergence of multi-resistant Enterococcus faecalis clonal complex, CC4, causing nosocomial infections. J Med Microbiol. 2018;67(8):1069–1077.
   PubMed Web of Science ®Google Scholar
• Team RC. R: A language and environment for statistical computing; 2019.
   Google Scholar
• Lumley T. Package ‘survey': analysis of complex survey samples; 2020.
   Google Scholar
• European Commission. Eurostat database 2020. Available from: https://ec.europa.eu/eurostat/data/database.
   Google Scholar
• Tacconelli E, Pezzani MD. Public health burden of antimicrobial resistance in Europe. Lancet Infect Dis. 2019;19(1):4–6.
   PubMed Web of Science ®Google Scholar
• Jonas OB, Irwin A, Berthe FCJ, et al. Drug-resistant infections: a threat to our economic future (Vol. 2): final report (English). Washington (DC): World Bank Group; 2017.
   Google Scholar
• Mendes RE, Sader HS, Castanheira M, et al. Distribution of main Gram-positive pathogens causing bloodstream infections in United States and European hospitals during the SENTRY antimicrobial surveillance Program (2010-2016): concomitant analysis of oritavancin in vitro activity. J Chemother. 2018;30(5):280–289.
   PubMed Web of Science ®Google Scholar
• Jabbari SM S, Pormohammad A, Hashemi A, et al. Global prevalence of antibiotic resistance in blood-isolated enterococcus faecalis and enterococcus faecium: A systematic review and meta-analysis. Infect Drug Resist. 2019;12:2713–2725.
   PubMed Web of Science ®Google Scholar
• Moghimbeigi A, Moghimbeygi M, Dousti M, et al. Prevalence of vancomycin resistance among isolates of enterococci in Iran: a systematic review and meta-analysis. Adolesc Health Med Ther. 2018;9:177–188.
   PubMed Web of Science ®Google Scholar
• Armin S, Zahedani SS, Rahbar M, et al. Prevalence and resistance profiles of vancomycin-resistant enterococcal isolates in Iran; an eight-month report from nine major cities. Infect Disord Drug Targets. 2019.
   Google Scholar
• Huang L, Zhang R, Hu Y, et al. Epidemiology and risk factors of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci infections in Zhejiang China from 2015 to 2017. Antimicrob Resist Infect Control. 2019;8:90.
   PubMed Web of Science ®Google Scholar
• Zhi ZYXZ. [Surveillance of bacterial resistance in children and newborns across China from 2014 to 2017]. Zhonghua yi xue za zhi. 2018;98(40):3279–3287.
   PubMedGoogle Scholar
• Hu F, Zhu D, Wang F, et al. Current status and trends of antibacterial resistance in China. Clin Infect Dis. 2018;67(suppl_2):S128–Ss34.
   PubMed Web of Science ®Google Scholar
• Cassini A, Högberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66.
   PubMed Web of Science ®Google Scholar
• Simner PJ, Adam H, Baxter M, et al. Epidemiology of vancomycin-resistant enterococci in Canadian hospitals (CANWARD study, 2007 to 2013). Antimicrob Agents Chemother. 2015;59(7):4315–4317.
   PubMed Web of Science ®Google Scholar
• Koppe U, von Laer A, Kroll LE, et al. Carbapenem non-susceptibility of Klebsiella pneumoniae isolates in hospitals from 2011 to 2016, data from the German antimicrobial resistance surveillance (ARS). Antimicrob Resist Infect Control. 2018;7:71.
   PubMed Web of Science ®Google Scholar
• Adam HJ, Baxter MR, Davidson RJ, et al. Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitals. J Antimicrob Chemother. 2013;68(Suppl 1):i31–i37.
   PubMed Web of Science ®Google Scholar
• Ji Z, Han F, Meng F, et al. The association of Age and antibiotic resistance of Helicobacter pylori: A study in Jiaxing City, Zhejiang Province, China. Medicine (Baltimore). 2016;95(8):e2831.
   PubMed Web of Science ®Google Scholar
• Garcia A, Delorme T, Nasr P. Patient age as a factor of antibiotic resistance in methicillin-resistant Staphylococcus aureus. J Med Microbiol. 2017;66(12):1782–1789.
   PubMed Web of Science ®Google Scholar
• Karki S, Houston L, Land G, et al. Prevalence and risk factors for VRE colonisation in a tertiary hospital in Melbourne, Australia: a cross sectional study. Antimicrob Resist Infect Control. 2012;1(1):31.
   PubMed Web of Science ®Google Scholar
• Augustine S, Bonomo RA. Taking stock of infections and antibiotic resistance in the elderly and long-term care facilities: A survey of existing and upcoming challenges. Eur J Microbiol Immunol (Bp. 2011;1(3):190–197.
   PubMedGoogle Scholar
• Laudisio A, Marinosci F, Gemma A, et al. The burden of comorbidity is associated with antibiotic resistance among institutionalized elderly with urinary infection: A retrospective Cohort study in a single Italian Nursing Home between 2009 and 2014. Microb Drug Resist. 2017;23(4):500–506.
   PubMed Web of Science ®Google Scholar
• Eurostat Statistics Explained. Hospital discharge and length of stay2019. 2020. Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php/Hospital_discharges_and_length_of_stay_statistics.
   Google Scholar
• Ramirez CB, Cantey JB. Antibiotic resistance in the neonatal intensive care unit. NeoReviews. 2019;20(3):e135–ee44.
   PubMedGoogle Scholar
• Yoshikawa TT. Antimicrobial resistance and aging: beginning of the end of the antibiotic era? J Am Geriatr Soc. 2002;50–57(Suppl):S226 -S229.
   Web of Science ®Google Scholar
• Beckett CL, Harbarth S, Huttner B. Special considerations of antibiotic prescription in the geriatric population. Clin Microbiol Infect. 2015;21(1):3–9.
   PubMed Web of Science ®Google Scholar
• Whelton E, Lynch C, O'Reilly B, et al. Vancomycin-resistant enterococci carriage in an acute Irish hospital. J Hosp Infect. 2016;93(2):175–180.
   PubMed Web of Science ®Google Scholar
• Donskey CJ. The role of the intestinal tract as a Reservoir and Source for transmission of nosocomial pathogens. Clin Infect Dis. 2004;39(2):219–226.
   PubMed Web of Science ®Google Scholar
• Abbo L, Shukla BS, Giles A, et al. Linezolid- and vancomycin-resistant Enterococcus faecium in Solid Organ Transplant Recipients: infection control and antimicrobial stewardship using whole genome sequencing. Clin Infect Dis. 2018;69(2):259–265.
   Web of Science ®Google Scholar
• Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart association. Circulation. 2015;132(15):1435–1486.
   PubMed Web of Science ®Google Scholar
• Hashemian SMR, Farhadi T, Ganjparvar M. Linezolid: a review of its properties, function, and use in critical care. Drug Des Devel Ther. 2018;12:1759–1767.
   PubMed Web of Science ®Google Scholar
• O'Driscoll T, Crank CW. Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infect Drug Resist. 2015;8:217–230.
   PubMed Web of Science ®Google Scholar
• Dilworth TJ, Beck ET, Pedersen RA, et al. High rate of linezolid intermediate susceptibility and resistance among enteric vancomycin-resistant Enterococcus (VRE) recovered from hospitalized patients actively screened for VRE colonization. Infection Control & Hospital Epidemiology. 2019;40(7):821–822.
   PubMed Web of Science ®Google Scholar
• Bonora MG, Solbiati M, Stepan E, et al. Emergence of linezolid resistance in the vancomycin-resistant Enterococcus faecium multilocus sequence typing C1 epidemic lineage. J Clin Microbiol. 2006;44(3):1153–1155.
   PubMed Web of Science ®Google Scholar
• Bender JK, Cattoir V, Hegstad K, et al. Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: towards a common nomenclature. Drug Resist Updates. 2018;40:25–39.
   PubMed Web of Science ®Google Scholar
• Wardenburg KE, Potter RF, D'Souza AW, et al. Phenotypic and genotypic characterization of linezolid-resistant Enterococcus faecium from the USA and Pakistan. J Antimicrob Chemother. 2019;74(12):3445–3452.
   PubMed Web of Science ®Google Scholar
• Davis HR, Brown RM, Ashcraft DS, et al. In vitro synergy of fosfomycin plus doxycycline against linezolid and vancomycin resistant Enterococcus faecium using a rapid test method and time-kill assay. J Invest Med. 2019;67(2):597.
   Web of Science ®Google Scholar
• Allan Coukell HB. The antibiotic market is broken—and won’t fix itself. The Pew Charitable Trusts; 2019.
   Google Scholar
• ECDC. External quality assessment of laboratory performance - European antimicrobial resistance surveillance Network (EARS-Net), 2017. Stockholm: European Centre for Disease Prevention and Control; 2018.
   Google Scholar